论文部分内容阅读
目的观察安珐特治疗慢性乙型肝炎肝脏纤维化的临床疗效。方法应用酶联免疫吸附法对口服安珐特治疗慢性乙型肝炎肝纤维化患者进行检测,观察用药前后血清肝纤维化(HA、LN、PC-Ⅲ、Ⅳ-C)的变化。结果治疗组治疗后血清肝纤维化各项指标均明显改善(P<0.05),与对照组比较差异有统计学意义(P<0.05)。结论安珐特有明显改善肝脏纤维化作用。
Objective To observe the clinical efficacy of Ann Retort in the treatment of liver fibrosis in patients with chronic hepatitis B. Methods Serum levels of liver fibrosis (HA, LN, PC-Ⅲ and Ⅳ-C) were measured by enzyme-linked immunosorbent assay (ELISA) in patients with chronic hepatitis B and liver fibrosis. Results The indexes of serum fibrosis in treatment group were significantly improved (P <0.05), and the difference was statistically significant compared with the control group (P <0.05). Conclusion Alloprofen significantly improved liver fibrosis.